Follow
Carlos Juan
Carlos Juan
Immunology associate professor (UIB), Microbiology Researcher Hospital Son Espases, Palma
Verified email at uib.cat
Title
Cited by
Cited by
Year
The increasing threat of Pseudomonas aeruginosa high-risk clones
A Oliver, X Mulet, C López-Causapé, C Juan
Drug Resistance Updates 21, 41-59, 2015
6282015
β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein
B Moya, A Dötsch, C Juan, J Blázquez, L Zamorano, S Haussler, A Oliver
PLoS pathogens 5 (3), e1000353, 2009
3212009
Role of Klebsiella pneumoniae OmpK35 Porin in Antimicrobial Resistance
A Doménech-Sánchez, L Martínez-Martínez, S Hernández-Allés, ...
Antimicrobial agents and chemotherapy 47 (10), 3332-3335, 2003
272*2003
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals
O Gutiérrez, C Juan, E Cercenado, F Navarro, E Bouza, P Coll, JL Pérez, ...
Antimicrobial agents and chemotherapy 51 (12), 4329-4335, 2007
2652007
Molecular Mechanisms of β-Lactam Resistance Mediated by AmpC Hyperproduction in Pseudomonas aeruginosa Clinical Strains
C Juan, MD Maciá, O Gutiérrez, C Vidal, JL Pérez, A Oliver
Antimicrobial agents and chemotherapy 49 (11), 4733-4738, 2005
2462005
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones
G Cabot, AA Ocampo-Sosa, MA Domínguez, JF Gago, C Juan, F Tubau, ...
Antimicrobial agents and chemotherapy 56 (12), 6349-6357, 2012
2452012
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC
G Cabot, S Bruchmann, X Mulet, L Zamorano, B Moyà, C Juan, ...
Antimicrobial agents and chemotherapy 58 (6), 3091-3099, 2014
2362014
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem
E Riera, G Cabot, X Mulet, M García-Castillo, R del Campo, C Juan, ...
Journal of antimicrobial chemotherapy 66 (9), 2022-2027, 2011
2282011
Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates
G Cabot, L Zamorano, B Moyà, C Juan, A Navas, J Blázquez, A Oliver
Antimicrobial agents and chemotherapy 60 (3), 1767-1778, 2016
2202016
Stepwise Upregulation of the Pseudomonas aeruginosa Chromosomal Cephalosporinase Conferring High-Level β-Lactam Resistance Involves Three AmpD …
C Juan, B Moyá, JL Pérez, A Oliver
Antimicrobial agents and chemotherapy 50 (5), 1780-1787, 2006
2162006
Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and …
J Oteo, K Diestra, C Juan, V Bautista, Â Novais, M Pérez-Vázquez, ...
International journal of antimicrobial agents 34 (2), 173-176, 2009
1962009
Hypermutation and the Preexistence of Antibiotic-Resistant Pseudomonas aeruginosa Mutants: Implications for Susceptibility Testing and Treatment of Chronic …
A Oliver, BR Levin, C Juan, F Baquero, J Blázquez
Antimicrobial agents and chemotherapy 48 (11), 4226-4233, 2004
1792004
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities
B Moyá, A Beceiro, G Cabot, C Juan, L Zamorano, S Alberti, A Oliver
Antimicrobial agents and chemotherapy 56 (9), 4771-4778, 2012
1762012
Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa
PA Fraile-Ribot, G Cabot, X Mulet, L Periañez, ML Martín-Pena, C Juan, ...
Journal of Antimicrobial Chemotherapy 73 (3), 658-663, 2018
1752018
Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections
C Juan, C Peña, A Oliver
The Journal of infectious diseases 215 (suppl_1), S44-S51, 2017
1552017
Biological markers of Pseudomonas aeruginosa epidemic high-risk clones
X Mulet, G Cabot, AA Ocampo-Sosa, MA Domínguez, L Zamorano, ...
Antimicrobial agents and chemotherapy 57 (11), 5527-5535, 2013
1432013
Metallo-β-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones
C Juan, L Zamorano, A Mena, S Albertí, JL Pérez, A Oliver
Journal of antimicrobial chemotherapy 65 (3), 474-478, 2010
1342010
Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum β-Lactamases GES-1 …
E Viedma, C Juan, J Acosta, L Zamorano, JR Otero, F Sanz, F Chaves, ...
Antimicrobial agents and chemotherapy 53 (11), 4930-4933, 2009
1342009
Activity of a New Cephalosporin, CXA-101 (FR264205), against β-Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after …
B Moya, L Zamorano, C Juan, JL Pérez, Y Ge, A Oliver
Antimicrobial agents and chemotherapy 54 (3), 1213-1217, 2010
1282010
Benefit of Having Multiple ampD Genes for Acquiring β-Lactam Resistance without Losing Fitness and Virulence in Pseudomonas aeruginosa
B Moya, C Juan, S Albertí, JL Pérez, A Oliver
Antimicrobial agents and chemotherapy 52 (10), 3694-3700, 2008
1272008
The system can't perform the operation now. Try again later.
Articles 1–20